Related Experiment Video

Updated: Jul 7, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

BCL6 represses Smad signaling in transforming growth factor-beta resistance

Degang Wang1, Jianyin Long, Fangyan Dai

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.

Cancer Research
|February 5, 2008
PubMed

Insights

The oncoprotein BCL6 acts as a corepressor for Smad4, inhibiting transforming growth factor-beta (TGF-beta) signaling. High BCL6 levels in lymphoma cells cause resistance to TGF-beta

Area of Science:

  • Molecular biology
  • Cellular signaling
  • Cancer research

Background:

  • Transforming growth factor-beta (TGF-beta) regulates critical cellular functions.
  • Dysregulated TGF-beta signaling is implicated in cancer and autoimmune diseases.
  • Smad proteins are key mediators of TGF-beta signal transduction.

Purpose of the Study:

  • To investigate the role of oncoprotein BCL6 in TGF-beta signaling.
  • To determine if BCL6 interacts with and affects Smad proteins.
  • To elucidate the contribution of BCL6 to TGF-beta resistance in B-cell lymphoma.

Main Methods:

  • Co-immunoprecipitation assays to assess protein interactions.
  • Reporter gene assays to measure transcriptional activity.
  • BCL6 knockdown experiments in B-cell lymphoma cell lines.

Main Results:

  • BCL6 physically interacts with Smad3 and Smad4.
  • BCL6 disrupts the Smad-p300 complex and represses Smad4 transcriptional activity.
  • High BCL6 expression confers resistance to TGF-beta antiproliferative effects in B-cell lymphoma.
  • Reducing BCL6 levels partially restores TGF-beta responsiveness.

Conclusions:

  • BCL6 functions as a transcriptional corepressor of Smad4.
  • Overexpression of BCL6 contributes to TGF-beta resistance in B-cell lymphoma.
  • Targeting BCL6 may represent a therapeutic strategy for overcoming TGF-beta resistance in certain cancers.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...